Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelomonocytic, Chronic × regorafenib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Neoplasms 3 Neoplasm Metastasis 3 Gastrointestinal Stromal Tumors 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Gallbladder Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bile Duct Neoplasms 2 Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Physician Education 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Noonan Syndrome 6 1 Metastatic Pancreatic Adenocarcinoma 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Insulinoma 1 Glucagonoma 1

Interventions

fludarabine phosphate 32 Cyclophosphamide 27 Whole-Body Irradiation 25 Mycophenolic Acid 24 Azacitidine 24 Tacrolimus 20 Peripheral Blood Stem Cell Transplantation 20 Busulfan 20 Cyclosporine 14 Methotrexate 12 Antilymphocyte Serum 12 Decitabine 11 Cytarabine 11 Melphalan 10 Filgrastim 8 fludarabine 7 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 thymoglobulin 6 Sirolimus 6 Rituximab 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 Clofarabine 6 venetoclax 5 Cyclosporins 5 Sorafenib 4 Injections 4 Flow Cytometry 4 pevonedistat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡